Showing results (1151-1160 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|July 19, 2001
Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagusM B Polee, T C Kok, P D Siersema, et al.Anti-Cancer Drugs|July 19, 2001
Peripheral neuropathy associated with weekly oral 5-fluorouracil, leucovorin and eniluracilM W Saif, R H Wilson, N Harold, et al.Anti-Cancer Drugs|July 19, 2001
Methyl protogracillin (NSC-698792): the spectrum of cytotoxicity against 60 human cancer cell lines in the National Cancer Institute's anticancer drug screen panelK Hu, X YaoAnti-Cancer Drugs|May 9, 2001
The current status of docetaxel for advanced non-small cell lung cancerM R GreenAnti-Cancer Drugs|April 20, 2001
[Chemotherapy of non-small cell lung cancer: non-cisplatin based combinations]O Rixe, J P Spano, J SeigneurAnti-Cancer Drugs|April 20, 2001
[Current treatment of bladder cancer: from epidemiology to surgical treatment]P RischmannAnti-Cancer Drugs|October 18, 2001
Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: effects on mouse mammary tumor cell line MM2 in vitro and in vivoY Takeda, I Yoshizaki, Y Nonaka, et al.Anti-Cancer Drugs|October 18, 2001
Characteristics of etoposide-induced apoptotic cell death in the U-937 human lymphoma cell lineP Martinsson, G Liminga, P Nygren, et al.Anti-Cancer Drugs|August 7, 2001
Thymidylate synthase as a molecular target for drug discovery using the National Cancer Institute's Anticancer Drug ScreenA L Parr, T G Myers, S L Holbeck, et al.Pageof 464